Literature DB >> 18315599

Myxoid tumours of soft tissue: the so-called myxoid extracellular matrix is heterogeneous in composition.

S M Willems1, Y M Schrage, J J Baelde, I Briaire-de Bruijn, A Mohseny, R Sciot, J V M G Bovée, P C W Hogendoorn.   

Abstract

AIM: Myxoid tumours of soft tissue are characterized by their so-called 'myxoid' extracellular matrix. The aim was to investigate the composition and possible function of this matrix which is poorly understood. METHODS AND
RESULTS: Using Alcian Blue staining with and without pretreatment with hyaluronidase and application of the critical electrolyte concentration method followed by densitometry, the glycosaminoglycan composition of three different myxoid tumours was studied. The composition of glycosaminoglycans varied with tumour type and grade, despite their general characterization as myxoid tumours. Intramuscular myxoma contained similar amounts of the various glycosaminoglycans as grade I myxofibrosarcoma; grade III myxofibrosarcoma contained less hyaluronic acid and more heparan sulphate, whereas extraskeletal myxoid chondrosarcoma contained predominantly chondroitin-4 and -6 sulphates. Western blot identified albumin as a major protein in tumour lysates, and its presence in the extracellular matrix and cytoplasm of the majority of tumours was demonstrated by immunohistochemistry; production of albumin by the tumour cells was confirmed by quantitative polymerase chain reaction.
CONCLUSIONS: The extracellular matrix of myxoid tumours of soft tissue has a heterogeneous composition consisting of, amongst others, glycosaminoglycans and albumin, which appear to play an active role in their morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18315599     DOI: 10.1111/j.1365-2559.2008.02967.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  14 in total

1.  Extraskeletal myxoid chondrosarcoma of the masticator space in a pediatric patient.

Authors:  Mário-José Romañach; Román Carlos; Michel Nuyens; Bruno-Augusto-Benevenuto de Andrade; Oslei-Paes de Almeida
Journal:  J Clin Exp Dent       Date:  2017-06-01

2.  NY-ESO-1 (CTAG1B) expression in mesenchymal tumors.

Authors:  Makoto Endo; Marieke A de Graaff; Davis R Ingram; Simin Lim; Dina C Lev; Inge H Briaire-de Bruijn; Neeta Somaiah; Judith V M G Bovée; Alexander J Lazar; Torsten O Nielsen
Journal:  Mod Pathol       Date:  2014-11-21       Impact factor: 7.842

3.  Aberrant heparan sulfate proteoglycan localization, despite normal exostosin, in central chondrosarcoma.

Authors:  Yvonne M Schrage; Liesbeth Hameetman; Karoly Szuhai; Anne-Marie Cleton-Jansen; Antonie H M Taminiau; Pancras C W Hogendoorn; Judith V M G Bovée
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

Review 4.  Running GAGs: myxoid matrix in tumor pathology revisited: what's in it for the pathologist?

Authors:  Stefan M Willems; Malgorzata Wiweger; J Frans Graadt van Roggen; Pancras C W Hogendoorn
Journal:  Virchows Arch       Date:  2009-08-25       Impact factor: 4.064

5.  Soft tissue sarcomas: introduction to the Virchows Archiv review issue.

Authors:  Louis Guillou; Pancras C W Hogendoorn; Fred T Bosman
Journal:  Virchows Arch       Date:  2010-02-18       Impact factor: 4.064

6.  Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and casein kinase II inhibition as a potential treatment option.

Authors:  Stefan M Willems; Yvonne M Schrage; Inge H Briaire-de Bruijn; Karoly Szuhai; Pancras C W Hogendoorn; Judith V M G Bovée
Journal:  Mol Cancer       Date:  2010-09-23       Impact factor: 27.401

7.  High-Throughput Screening of Myxoid Liposarcoma Cell Lines: Survivin Is Essential for Tumor Growth.

Authors:  Marieke A de Graaff; Shruti Malu; Irma Guardiola; Alwine B Kruisselbrink; Yvonne de Jong; Willem E Corver; H Gelderblom; Patrick Hwu; Torsten O Nielsen; Alexander J Lazar; Neeta Somaiah; Judith V M G Bovée
Journal:  Transl Oncol       Date:  2017-06-24       Impact factor: 4.243

8.  Recurrent myxoinflammatory fibroblastic sarcoma: a case report.

Authors:  Niveditha Jagadesh; Daniel H Miller; William Schenk; Steven Attia; Courtney E Sherman; Cherise Cortese; Byron C May; Robert C Miller
Journal:  Clin Case Rep       Date:  2017-04-20

9.  Cytogenetics and molecular genetics of myxoid soft-tissue sarcomas.

Authors:  Jun Nishio; Hiroshi Iwasaki; Kazuki Nabeshima; Masatoshi Naito
Journal:  Genet Res Int       Date:  2011-07-28

10.  Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix.

Authors:  Stefan M Willems; Alex B Mohseny; Crina Balog; Raj Sewrajsing; Inge H Briaire-de Bruijn; Jeroen Knijnenburg; Anne-Marie Cleton-Jansen; Raf Sciot; Christopher D M Fletcher; André M Deelder; Karoly Szuhai; Paul J Hensbergen; Pancras C W Hogendoorn
Journal:  J Cell Mol Med       Date:  2009-03-13       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.